9th Oct 2006 12:05
Hikma Pharmaceuticals Plc09 October 2006 Block Listing - Six Monthly Review Name of Company: Hikma Pharmaceuticals PLC Name of scheme: Hikma Pharmaceuticals PLC 2004 Stock Option Plan Period of return: From: 5 April 2006 To: 9 October 2006 Balance under block scheme: 4,058,400 ordinary shares of 10 pence each The amount by which the block scheme has Nilbeen increased, if the scheme has beenincreased since the date of the lastreturn: Number of securities issued/allotted 865,200 ordinary shares of 10 pence eachunder scheme during period: Balance under scheme not yet issued/ 3,193,200 ordinary shares of 10 penceallotted at end of period each Number and class of securities originally 166,537,951 ordinary shares of 10 pencelisted and the date of admission each originally listed on 1 November 2005 Total number of securities in issue at 167,663,607 ordinary shares of 10 pencethe end of the period each - ENDS - Enquiries: Hikma Pharmaceuticals PLC +44 20 7399 2670Henry Knowles, Company SecretarySusan Ringdal, Investor Relations Director Notes to Editors About Hikma Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused ondeveloping, manufacturing and marketing a broad range of both branded andnon-branded generic and in-licensed pharmaceutical products. Hikma's operationsare conducted through three businesses: Generic, Branded and InjectablePharmaceuticals. Hikma's operations are based principally in the United States,the Middle East and North Africa ("MENA") region and Europe. In 2005, the Grouphad revenue of $262 million and profit attributable to shareholders of $44million. At 31 December 2005, the Group had over 1,800 employees. For news andother information, please visit www.hikma.com. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Hikma Pharmaceuticals